EXACT THERAP. AS NK 0004
EXACT Therapeutics AS, a clinical stage biopharmaceutical company, develops a technology platform for targeted therapeutic enhancement, Acoustic Cluster Therapy (ACT). The ACT is an approach to ultrasound-mediated, targeted drug enhancement with the potential to amplify the clinical utility of a range of therapeutic agents across various indications, including within oncology and brain diseases. … Read more
Market Cap & Net Worth: EXACT THERAP. AS NK 0004 (56F)
EXACT THERAP. AS NK 0004 (F:56F) has a market capitalization of $9.74 Million (€9.49 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #33591 globally and #3805 in its home market, demonstrating a 30.43% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying EXACT THERAP. AS NK 0004's stock price €0.15 by its total outstanding shares 63263347 (63.26 Million).
EXACT THERAP. AS NK 0004 Market Cap History: 2021 to 2026
EXACT THERAP. AS NK 0004's market capitalization history from 2021 to 2026. Data shows change from $114.94 Million to $9.74 Million (-43.40% CAGR).
EXACT THERAP. AS NK 0004 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how EXACT THERAP. AS NK 0004's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 56F by Market Capitalization
Companies near EXACT THERAP. AS NK 0004 in the global market cap rankings as of March 19, 2026.
Key companies related to EXACT THERAP. AS NK 0004 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
EXACT THERAP. AS NK 0004 Historical Marketcap From 2021 to 2026
Between 2021 and today, EXACT THERAP. AS NK 0004's market cap moved from $114.94 Million to $ 9.74 Million, with a yearly change of -43.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €9.74 Million | +66.67% |
| 2025 | €5.84 Million | -66.42% |
| 2024 | €17.40 Million | -74.23% |
| 2023 | €67.54 Million | -1.89% |
| 2022 | €68.83 Million | -40.11% |
| 2021 | €114.94 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of EXACT THERAP. AS NK 0004 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.74 Million USD |
| MoneyControl | $9.74 Million USD |
| MarketWatch | $9.74 Million USD |
| marketcap.company | $9.74 Million USD |
| Reuters | $9.74 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.